Gene · 2348
Papers3,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10. | Neoplasia | 2024 | 39366148 | PubTator, text mining | PubMed |
| Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma. | Gynecol Oncol | 2024 | 39366033 | PubTator, text mining | PubMed |
| Accumulation of Cerebrospinal Fluid, Ventricular Enlargement, and Cerebral Folate Metabolic Errors Unify a Diverse Group of Neuropsychiatric Conditions Affecting Adult Neocortical Functions. | Int J Mol Sci | 2024 | 39337690 | PubTator, text mining | PubMed |
| Emerging Targets in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2024 | 39337530 | PubTator, text mining | PubMed |
| Case Report: Cerebral folate deficiency caused by FOLR1 variant. | Front Pediatr | 2024 | 39328591 | PubTator, text mining | PubMed |
| Colocalization of Cancer-Associated Biomarkers on Single Extracellular Vesicles for Early Detection of Cancer. | J Mol Diagn | 2024 | 39326670 | PubTator, text mining | PubMed |
| Alteration in folate carrier expression via histone deacetylase inhibition in BeWo human placental choriocarcinoma cells. | Toxicol In Vitro | 2024 | 39237058 | PubTator, text mining | PubMed |
| Unraveling the role of bisphenol A in osteosarcoma biology: insights into prognosis and immune microenvironment modulation. | Discov Oncol | 2024 | 39230832 | PubTator, text mining | PubMed |
| Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood-Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery. | Pharmaceuticals (Basel) | 2024 | 39204177 | PubTator, text mining | PubMed |
| CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target. | J Clin Invest | 2024 | 39145456 | PubTator, text mining | PubMed |
| PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis. | Reprod Biol Endocrinol | 2024 | 39085882 | PubTator, text mining | PubMed |
| Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer. | Future Oncol | 2024 | 39082675 | PubTator, text mining | PubMed |
| Mirvetuximab after anaphylaxis to Paclitaxel: A case report. | Gynecol Oncol Rep | 2024 | 39076678 | PubTator, text mining | PubMed |
| The clinical landscape of antibody-drug conjugates in endometrial cancer. | Int J Gynecol Cancer | 2024 | 39074933 | PubTator, text mining | PubMed |
| Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial. | Gynecol Oncol | 2024 | 39068739 | PubTator, text mining | PubMed |
| Delaying Brain Aging or Decreasing Tau Levels as Strategies to Prevent Alzheimer's Disease: In Memoriam of Mark A. Smith. | J Alzheimers Dis | 2024 | 39058443 | PubTator, text mining | PubMed |
Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer. | EJNMMI Radiopharm Chem | 2024 | 39048805 | PubTator, text mining | PubMed |
| Investigation of the synergistic effect mechanism underlying sequential use of palbociclib and cisplatin through integral proteomic and glycoproteomic analysis. | Anticancer Drugs | 2024 | 39011652 | PubTator, text mining | PubMed |
| Evolving treatment paradigms for platinum-resistant ovarian cancer: An update narrative review. | Taiwan J Obstet Gynecol | 2024 | 39004472 | PubTator, text mining | PubMed |
| Antibody-drug conjugate targeting folate receptor α: a new milestone in personalized medicine for high-grade serous ovarian cancer. | Int J Gynecol Cancer | 2024 | 38991657 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2348/papers?page=17